Overview

Antibiotic Prophylaxis in Pediatric Open Fractures

Status:
Enrolling by invitation
Trial end date:
2034-01-01
Target enrollment:
Participant gender:
Summary
This research will involve a prospective study on infection rates after grade 1 or 2 open fractures in the skeletally immature pediatric population. There will be 3 arms: one dose intravenous cefazolin, 24 hours intravenous cefazolin, and 24 hours intravenous cefazolin plus 5 days of oral cephalexin.
Phase:
Phase 4
Details
Lead Sponsor:
St. Louis University
Treatments:
Cefazolin
Cephalexin